119 related articles for article (PubMed ID: 17940561)
1. [Expressions of ERCC2 and ERCC4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
[TBL] [Abstract][Full Text] [Related]
2. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
3. Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.
Hao T; Feng W; Zhang J; Sun YJ; Wang G
Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Yang LM; Li XH; Bao CF
Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
[TBL] [Abstract][Full Text] [Related]
5. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of DNA repair genes (XRCC1, ERCC1, ERCC2, and ERCC4) in squamous intraepithelial lesion and invasive squamous cell carcinoma of the cervix.
Bajpai D; Banerjee A; Pathak S; Jain SK; Singh N
Mol Cell Biochem; 2013 May; 377(1-2):45-53. PubMed ID: 23435956
[TBL] [Abstract][Full Text] [Related]
7. [Expression of genes of potential importance in the response to chemotherapy in osteosarcoma patients].
Nathrath M; Kremer M; Letzel H; Remberger K; Höfler H; Ulle T
Klin Padiatr; 2002; 214(4):230-5. PubMed ID: 12165907
[TBL] [Abstract][Full Text] [Related]
8. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study.
Wong IH; Chan AT; Johnson PJ
Clin Cancer Res; 2000 Jun; 6(6):2183-8. PubMed ID: 10873067
[TBL] [Abstract][Full Text] [Related]
10. Role of ERCC2 and ERCC3 gene polymorphisms in the development of osteosarcoma.
Ma X; Zhang Y; Sun TS; Yao JH
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051024
[TBL] [Abstract][Full Text] [Related]
11. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
[TBL] [Abstract][Full Text] [Related]
12. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
Jian Y; Tian X; Li B; Zhou Z; Wu X
Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
[TBL] [Abstract][Full Text] [Related]
13. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer.
Lee SA; Lee KM; Park WY; Kim B; Nam J; Yoo KY; Noh DY; Ahn SH; Hirvonen A; Kang D
Exp Mol Med; 2005 Apr; 37(2):86-90. PubMed ID: 15886521
[TBL] [Abstract][Full Text] [Related]
14. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
[TBL] [Abstract][Full Text] [Related]
16. The link of ERCC2 rs13181 and ERCC4 rs2276466 polymorphisms with breast cancer in the Bangladeshi population.
Sahaba SA; Rashid MA; Islam MS; Nahid NA; Apu MNH; Sultana TN; Chaity NI; Hasan MM; Islam MS
Mol Biol Rep; 2022 Mar; 49(3):1847-1856. PubMed ID: 34837148
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of nucleotide excision repair genes is associated with chronic arsenic poisoning.
Zhang A; Li H; Xiao Y; Chen L; Zhu X; Li J; Ma L; Pan X; Chen W; He Z
Biomarkers; 2017 Jul; 22(5):429-438. PubMed ID: 27685703
[TBL] [Abstract][Full Text] [Related]
18. Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.
Liu ZF; Asila AL; Aikenmu K; Zhao J; Meng QC; Fang R
Genet Mol Res; 2015 Oct; 14(4):12967-72. PubMed ID: 26505449
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
[TBL] [Abstract][Full Text] [Related]
20. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]